> But stem cell treatment as a whole has already delivered.
Clinical trials underway does not equal delivered. In the 3 years since your review article talking about future applications none of these hypothetical applications have been delivered yet.
Source? To my knowledge what’s approved is not iPSC.
Hematopoietic progenitors are a different challenge and “low hanging fruit”.
https://www.fda.gov/vaccines-blood-biologics/cellular-gene-t...
> But stem cell treatment as a whole has already delivered.
Clinical trials underway does not equal delivered. In the 3 years since your review article talking about future applications none of these hypothetical applications have been delivered yet.